Exchange: NASDAQ·Updated 04:15 PM EST

ETRA Electra Therapeautics

$8.11
$0.83
(9.28%)
Today
Closed $8.11
$0.00
(0.00%)
After Hours
Reported EarningsNov 12
Mkt Cap$509.85M
Vol376,123.00

About ETRA

Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
32

Bearish Sentiment

How do you feel about ETRA?

openmarketalerts
$ETRA — Director Orbimed Advisors LLC bought $745K of stock from Nov 6 to Nov 10. 92,116 shares.
2
AlertsAndNews
$ETRA Insider action here Electra Therapeutics Form 4, Insider Buy Carl L. Gordon (Director, 10%+ Reporting Person) Reports 92,116 Shares Bought @ $8.08 Avg., totaling approximately $744,297 through OrbiMed-related funds.
1
openmarketalerts
$ETRA: $3.6M of stock bought by Director Orbimed Advisors LLC from Nov 3 to Nov 5. 472,571 shares.
1

Advertisement|Remove ads.